CD4+ T细胞活化过程中的NOTCH1信号改变转录因子网络并增强抗原反应性
本研究利用无细胞培养系统在初始CD4+ T细胞活化及CAR-T制备过程中提供激动性NOTCH1信号,发现NOTCH1激动可诱导干细胞记忆表型、上调AhR和c-MAF并促进IL-22、IL-10和颗粒酶B产生,NOTCH1激动的CD4+ CAR-T在小鼠淋巴瘤异种移植模型中增殖频率显著更高,并对共转移的CD8+ CAR-T提供更优辅助,驱动改善的扩增和治愈性抗肿瘤反应。
要点
- NOTCH1激动有效诱导初始CD4+ CAR-T干细胞记忆表型,对记忆CD4+ CAR-T无此作用。
- NOTCH1激动上调AhR和c-MAF,驱动IL-22、IL-10和颗粒酶B产生增加。
- NOTCH1激动的CD4+ CAR-T增强抗原反应性,在小鼠体内增殖频率显著更高并提供更优辅助。
核心结论
- 数据扩展了NOTCH塑造CD4+ T细胞行为的机制,并表明在体外基因修饰过程中激活NOTCH1信号是增强肿瘤靶向受体工程化T细胞功能的潜在策略。
研究设计与样本
- 研究采用无细胞培养系统,在初始CD4+ T细胞活化及CAR-T生产过程中提供激动性NOTCH1信号,并研究其对分化、转录因子表达、细胞因子产生和肿瘤反应的影响。
主要发现
- NOTCH1激动有效诱导来自初始而非记忆CD4+ T细胞的CAR-T呈现干细胞记忆表型。
- NOTCH1激动上调AhR和c-MAF表达,驱动白细胞介素-22、白细胞介素-10和颗粒酶B产生增加。
- NOTCH1激动的CD4+ CAR-T表现出增强的抗原反应性,在携带人淋巴瘤异种移植瘤的小鼠中增殖至显著更高的频率。
- NOTCH1激动的CD4+ CAR-T对共转移的CD8+ CAR-T提供更优辅助,在低CAR-T剂量下驱动改善的扩增和治愈性抗肿瘤反应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adoptive transfer of T cells expressing chimeric antigen receptors (CAR-T) effectively treats refractory hematologic malignancies in a subset of patients but can be limited by poor T-cell expansion and persistence in vivo. Less differentiated T-cell states correlate with the capacity of CAR-T to proliferate and mediate antitumor responses, and interventions that limit tumor-specific T-cell differentiation during ex vivo manufacturing enhance efficacy. NOTCH signaling is involved in fate decisions across diverse cell lineages and in memory CD8+ T cells was reported to upregulate the transcription factor FOXM1, attenuate differentiation, and enhance proliferation and antitumor efficacy in vivo. Here, we used a cell-free culture system to provide an agonistic NOTCH1 signal during naïve CD4+ T-cell activation and CAR-T production and studied the effects on differentiation, transcription factor expression, cytokine production, and responses to tumor. NOTCH1 agonism efficiently induced a stem cell memory phenotype in CAR-T derived from naïve but not memory CD4+ T cells and upregulated expression of AhR and c-MAF, driving heightened production of interleukin-22, interleukin-10, and granzyme B. NOTCH1-agonized CD4+ CAR-T demonstrated enhanced antigen responsiveness and proliferated to strikingly higher frequencies in mice bearing human lymphoma xenografts. NOTCH1-agonized CD4+ CAR-T also provided superior help to cotransferred CD8+ CAR-T, driving improved expansion and curative antitumor responses in vivo at low CAR-T doses. Our data expand the mechanisms by which NOTCH can shape CD4+ T-cell behavior and demonstrate that activating NOTCH1 signaling during genetic modification ex vivo is a potential strategy for enhancing the function of T cells engineered with tumor-targeting receptors.
引用
- Wilkens AB, Fulton EC, Pont MJ, et al. NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness. Blood. 2022. PMID: 35605191. doi:10.1182/blood.2021015144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。